CLINICAL TRIALS PROFILE FOR ACETOHYDROXAMIC ACID
✉ Email this page to a colleague
All Clinical Trials for acetohydroxamic acid
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT02670889 ↗ | Manipulating the Gut Microbiome Study | Terminated | Children's Hospital of Philadelphia | Phase 1/Phase 2 | 2017-03-24 | The objective is to determine if acetohydroxamic acid (AHA) can prevent hydrolysis of urea by inhibiting the bacterial urease of gut flora of both healthy control adults as well as adults with urea cycle disorders |
| NCT02670889 ↗ | Manipulating the Gut Microbiome Study | Terminated | Data Management and Coordinating Center (DMCC) | Phase 1/Phase 2 | 2017-03-24 | The objective is to determine if acetohydroxamic acid (AHA) can prevent hydrolysis of urea by inhibiting the bacterial urease of gut flora of both healthy control adults as well as adults with urea cycle disorders |
| NCT02670889 ↗ | Manipulating the Gut Microbiome Study | Terminated | Nicholas Ah Mew | Phase 1/Phase 2 | 2017-03-24 | The objective is to determine if acetohydroxamic acid (AHA) can prevent hydrolysis of urea by inhibiting the bacterial urease of gut flora of both healthy control adults as well as adults with urea cycle disorders |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for acetohydroxamic acid
Condition Name
| Condition Name for acetohydroxamic acid | |
| Intervention | Trials |
| Urea Cycle Disorder | 2 |
| Argininosuccinate Synthetase Deficiency (Citrullinemia) | 1 |
| Argininosuccinic Acid Lyase Deficiency (Argininosuccinic Aciduria) | 1 |
| [disabled in preview] | 0 |
| This preview shows a limited data set Subscribe for full access, or try a Trial | |
Clinical Trial Locations for acetohydroxamic acid
Trials by Country
Clinical Trial Progress for acetohydroxamic acid
Clinical Trial Phase
Clinical Trial Sponsors for acetohydroxamic acid
Sponsor Name
